1. Role: Director. Scope: Department. Date: 2019.
Grant H. Skrepnek, Ph.D., R.Ph.
Professor
Pharmacy Clinical & Admin Sci
Phone (405) 271-6878 x47105
Fax (4050 271-6430
Office CPB 214
Email grant-skrepnek@ouhsc.edu
Summary
I concentrate on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, I focus on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. I am engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.
Research
Dr. Skrepnek concentrates on health economics, policy, and outcomes research involving large-scale database investigations, decision analyses, clinical trials, and survey research. From a clinical stance, Dr. Skrepnek focuses on studying cost, quality, and access to care across various healthcare settings concerning oncology, cardiopulmonary disease, rare conditions, and comorbidities. He is engaged in advancing the methodological approaches used within assessments of health technology, including the development of novel statistical procedures to evaluate health and economic data.
Publications & Presentations
- 91. Harshman R S, Richerson G T, Hadker N, Greene B L, Brown T M, Foster T S, Turner B H, Skrepnek S H, Doyle J J. Impact of a hypertension management/health promotion program on commercial driver's license employees of a self-insured utility company. Journal of occupational and environmental medicine. 2008; 50 : 359-65
92. Wang M T, Skrepnek G H, Armstrong E, Sherrill D L, Harris R B, Tsai C L, Malone D C. Use of salmeterol with and without concurrent use of inhaled corticosteroids and the risk of asthma-related hospitalization among patients with asthma. Current medical research and opinion. 2008; 24 : 859-67
93. Ko Y, Malone D C, Skrepnek G H, Armstrong E P, Murphy J E, Abarca J, Rehfeld R A, Reel S J, Woosley R L. Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers. Drug safety. 2008; 31 : 525-36
94. Grizzle A J, Mahmood M H, Ko Y, Murphy J E, Armstrong E P, Skrepnek G H, Jones W N, Schepers G P, Nichol W P, Houranieh A, Dare D C, Hoey C T, Malone D C. Reasons provided by prescribers when overriding drug-drug interaction alerts. The American journal of managed care. 2007; 13 : 573-8
95. Mahmood M, Malone D C, Skrepnek G H, Abarca J, Armstrong E P, Murphy J E, Grizzle A J, Ko Y, Woosley R L. Potential drug-drug interactions within Veterans Affairs medical centers. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2007; 64 : 1500-5
Grants
- 11. Improving the Health of Americans through Prevention and Management of Diabetes, Heart Disease, and Stroke. Non-federal. Start Date: 2019. End Date: 2020.
12. Allergan (PI: Keast). Federal Non-NIH. Start Date: 2018. End Date: 2019.
13. Otsuka (Skrepnek/Keast PI). Non-federal. Start Date: 2018. End Date: 2019.
14. Research Fellowship. PhRMA. Start Date: 2017. End Date: 2018.
15. Development of a Predictive Model for METAVIR Fibrosis Scores for Patients Chronically Infected with Hepatitis C Virus. Misc Non-Federal. Start Date: 2017.
Awards and Honors
no results
Education
no results
Administrative Assignments
2. Role: Director. Scope: Department. Description: Interim Director & Director of Academic Research. Date: 2019.